AstraZeneca wins federal class-action suit, judge dismisses shareholders' misleading claims
AstraZeneca never got its Covid-19 vaccine authorized in the US, and while shareholders have tried taking the UK pharma to court, a judge has now squashed that effort.
Federal Judge Paul Oetken of the US Southern District of New York approved the pharma company’s motion Monday to dismiss a class action suit. The lawsuit alleged the company made misleading statements about the clinical testing of its Covid-19 vaccine candidate AZD1222.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.